Yeager, M. E., Gouhier, T. C., & Hughes, A. R. (2020, Apr). Predicting the stability of multitrophic communities in a variable world. Ecology, 101(4), e02992. https://doi.org/10.1002/ecy.2992


Waugh, K. A., Araya, P., Pandey, A., Jordan, K. R., Smith, K. P., Granrath, R. E., Khanal, S., Butcher, E. T., Estrada, B. E., Rachubinski, A. L., McWilliams, J. A., Minter, R., Dimasi, T., Colvin, K. L., Baturin, D., Pham, A. T., Galbraith, M. D., Bartsch, K. W., Yeager, M. E., Porter, C. C., Sullivan, K. D., Hsieh, E. W., & Espinosa, J. M. (2019, Nov 12). Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome. Cell Reports, 29(7), 1893-1908.e1894. https://doi.org/10.1016/j.celrep.2019.10.038


Gally, F., Rao, D. M., Schmitz, C., Colvin, K. L., Yeager, M. E., & Perraud, A. L. (2018, Jan). The TRPM2 ion channel contributes to cytokine hyperproduction in a mouse model of Down Syndrome. Biochim Biophys Acta Mol Basis Dis, 1864(1), 126-132. https://doi.org/10.1016/j.bbadis.2017.09.025


Colvin, K. L., Ivy, D. D., & Yeager, M. E. (2017, Mar). Altered Peripheral Blood Myeloid Cell Subpopulations in Children With Down Syndrome and Pulmonary Hypertension. Journal of Pediatric Hematology/Oncology, 39(2), 158-159. https://doi.org/10.1097/mph.0000000000000727 Colvin, K. L., & Yeager, M. E. (2017, Jan). What people with Down Syndrome can teach us about cardiopulmonary disease. European Respiratory Review: An Official Journal of the European Respiratory Society, 26(143). https://doi.org/10.1183/16000617.0098-2016 Schäfer, M., Barker, A. J., Kheyfets, V., Stenmark, K. R., Crapo, J., Yeager, M. E., Truong, U., Buckner, J. K., Fenster, B. E., & Hunter, K. S. (2017, Dec 20). Helicity and Vorticity of Pulmonary Arterial Flow in Patients With Pulmonary Hypertension: Quantitative Analysis of Flow Formations. J Am Heart Assoc, 6(12). https://doi.org/10.1161/jaha.117.007010 Yeager, M. E., & Hovel, K. A. (2017, Oct). Structural complexity and fish body size interactively affect habitat optimality. Oecologia, 185(2), 257- 267. https://doi.org/10.1007/s00442-017-3932-2


Colvin, K. L., & Yeager, M. E. (2015a). Applying Biotechnology and Bioengineering to Pediatric Lung Disease: Emerging Paradigms and Platforms. Front Pediatr, 3, 45. https://doi.org/10.3389/fped.2015.00045 Colvin, K. L., & Yeager, M. E. (2015b, Feb). Proteomics of pulmonary hypertension: could personalized profiles lead to personalized medicine? Proteomics: Clinical Applications, 9(1-2), 111-120. https://doi.org/10.1002/prca.201400157 Lohani, O., Colvin, K. L., & Yeager, M. E. (2015, Sep). Biomarkers for pediatric pulmonary arterial hypertension: challenges and recommendations. Paediatric Respiratory Reviews, 16(4), 225-231. https://doi.org/10.1016/j.prrv.2015.05.003


Colvin, K. L., Dufva, M. J., Delaney, R. P., Ivy, D. D., Stenmark, K. R., & Yeager, M. E (2014). Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate. Front Pediatr, 2, 7. https://doi.org/10.3389/fped.2014.00007 Colvin, K. L., & Yeager, M. E. (2014, Aug 4). Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease. J Pulm Respir Med, 4(4). https://doi.org/10.4172/2161-105x.1000198 Wang, D., Zhang, H., Li, M., Frid, M. G., Flockton, A. R., McKeon, B. A., Yeager, M. E., Fini, M. A., Morrell, N. W., Pullamsetti, S. S., Velegala, S., Seeger, W., McKinsey, T. A., Sucharov, C. C., & Stenmark, K. R. (2014, Jan 3). MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circulation Research, 114(1), 67-78. https://doi.org/10.1161/circresaha.114.301633 Williams, S. M., Golden-Mason, L., Ferguson, B. S., Schuetze, K. B., Cavasin, M. A., Demos-Davies, K., Yeager, M. E., Stenmark, K. R., & McKinsey, T. A. (2014, Feb). Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. Journal of Molecular and Cellular Cardiology, 67, 112-125. https://doi.org/10.1016/j.yjmcc.2013.12.013


Colvin, K. L., Cripe, P. J., Ivy, D. D., Stenmark, K. R., & Yeager, M. E. (2013, Nov 1). Bronchus-associated lymphoid tissue in pulmonary hypertension produces pathologic autoantibodies. American journal of respiratory and critical care medicine, 188(9), 1126-1136. https://doi.org/10.1164/rccm.201302-0403OC Stenmark, K. R., Yeager, M. E., El Kasmi, K. C., Nozik-Grayck, E., Gerasimovskaya, E. V., Li, M., Riddle, S. R., & Frid, M. G. (2013). The adventitia: essential regulator of vascular wall structure and function. Annual Review of Physiology, 75, 23-47. https://doi.org/10.1146/annurev-physiol-030212-183802 Villegas, L. R., Kluck, D., Field, C., Oberley-Deegan, R. E., Woods, C., Yeager, M. E., El Kasmi, K. C., Savani, R. C., Bowler, R. P., & Nozik-Grayck, E. (2013, May 10). Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome. Antioxidants and Redox Signaling, 18(14), 1753-1764. https://doi.org/10.1089/ars.2012.4799


Cavasin, M. A., Demos-Davies, K., Horn, T. R., Walker, L. A., Lemon, D. D., Birdsey, N., Weiser-Evans, M. C., Harral, J., Irwin, D. C., Anwar, A., Yeager, M. E., Li, M., Watson, P. A., Nemenoff, R. A., Buttrick, P. M., Stenmark, K. R., & McKinsey, T. A. (2012, Mar 2). Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism. Circulation Research, 110(5), 739-748. https://doi.org/10.1161/circresaha.111.258426 Yeager, M. E., Belchenko, D. D., Nguyen, C. M., Colvin, K. L., Ivy, D. D., & Stenmark, K. R. (2012, Jan). Endothelin-1, the unfolded protein response, and persistent inflammation: role of pulmonary artery smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology, 46(1), 14-22. https://doi.org/10.1165/rcmb.2010-0506OC Yeager, M. E., Colvin, K. L., Everett, A. D., Stenmark, K. R., & Ivy, D. D. (2012, Jun). Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension. Proteomics: Clinical Applications, 6(5-6), 257-267. https://doi.org/10.1002/prca.201100078 Yeager, M. E., Nguyen, C. M., Belchenko, D. D., Colvin, K. L., Takatsuki, S., Ivy, D. D., & Stenmark, K. R. (2012a, Jan). Circulating fibrocytes are increased in children and young adults with pulmonary hypertension. European Respiratory Journal, 39(1), 104-111. https://doi.org/10.1183/09031936.00072311 Yeager, M. E., Nguyen, C. M., Belchenko, D. D., Colvin, K. L., Takatsuki, S., Ivy, D. D., & Stenmark, K. R. (2012b, Apr). Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension. Chest, 141(4), 944-952. https://doi.org/10.1378/chest.11-0205 Yeager, M. E., Reddy, M. B., Nguyen, C. M., Colvin, K. L., Ivy, D. D., & Stenmark, K. R.(2012, Apr-Jun). Activation of the unfolded protein response is associated with pulmonary hypertension. Pulmonary circulation, 2(2), 229-240. https://doi.org/10.4103/2045-8932.97613


Li, M., Riddle, S. R., Frid, M. G., El Kasmi, K. C., McKinsey, T. A., Sokol, R. J., Strassheim, D., Meyrick, B., Yeager, M. E., Flockton, A. R., McKeon, B. A., Lemon, D. D., Horn, T. R., Anwar, A., Barajas, C., & Stenmark, K. R. (2011, Sep 1). Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. Journal of Immunology, 187(5), 2711 - 2722. https://doi.org/10.4049/jimmunol.1100479 Yeager, M. E., Frid, M. G., & Stenmark, K. R. (2011, Jan-Mar). Progenitor cells in pulmonary vascular remodeling. Pulmonary circulation, 1(1), 3-16. https://doi.org/10.4103/2045-8932.78095


Stenmark, K. R., Frid, M. G., & Yeager, M. E. (2010, Dec). Fibrocytes: potential new therapeutic targets for pulmonary hypertension? European Respiratory Journal, 36(6),1232-1235. https://doi.org/10.1183/09031936.00137410


© 2016 by The Michael Yeager Lab 

  • Twitter
  • Facebook
  • Instagram